Participants supplemented with 12 mg per day (n=19), 6 mg per day (n=22), or 0 mg per day (n=18) AstaReal astaxanthin softgels from summer to winter, over the course of 16 weeks
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
Before-and-after guidance: what to keep in mind Ask your provider what a realistic, individualized timeline looks like for your specific situation Track how you feel honestly rather than comparing yourself to anecdotes online Bring questions and observations to every scheduled follow-up Understand that stopping therapy generally means stopping any changes associated with it No outcome is guaranteed
Running these together during a loading phase (especially for joint, tendon, or connective tissue goals) is a well-established protocol